Analystreport

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $111.00 price target on the stock.

Axsome Therapeutics, Inc.  (AXSM) 
Last axsome therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com